FDA Tacks on 3 More Chinese Drugmakers to Import Alert Lists

International Pharmaceutical Regulatory Monitor
A A
The FDA is continuing its crackdown on Chinese drugmakers, adding three more companies this week to its import alert lists over faulty GMP practices and a refusal for inspection.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor